{"id":1470555,"title":"DSEN Abstract: How does real world use of insulin glargine compare to NPH insulin in terms of effectiveness and safety for the management of type 1 diabetes mellitus (T1DM)? - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-07","captureTimestamp":"2026-04-07T17:44:57.921000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/51607.html?wbdisable=true","snippet":"DSEN Abstract How does real world use of insulin glargine compare to NPH insulin in terms of effectiveness and safety for the management of type 1 diabetes mellitus (T1DM)? This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following…","rawSnapshotUrl":"/api/snapshots/raw/1470555","browseUrl":"https://replay.healtharchive.ca/job-8/20260407174457/https://cihr-irsc.gc.ca/e/51607.html?wbdisable=true#ha_snapshot=1470555","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}